Full text
PDF![712](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3386/1881525/6440524e54af/bmj00064-0068.png)
![713](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3386/1881525/70f78c6ff4f2/bmj00064-0069.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davey Smith G., Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. 1992 Feb 15;304(6824):431–434. doi: 10.1136/bmj.304.6824.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsevat J., Weinstein M. C., Williams L. W., Tosteson A. N., Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991 Apr;83(4):1194–1201. doi: 10.1161/01.cir.83.4.1194. [DOI] [PubMed] [Google Scholar]
- Wysowski D. K., Gross T. P. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med. 1990 Oct;150(10):2169–2172. [PubMed] [Google Scholar]